Phase 3 Study of Lyrica for Central Neuropathic Pain - MPR
Links shared publicly online about this topic.
- 202total visits
Phase 3 Study of Lyrica for Central Neuropathic Pain - MPR
empr.com —
View full resource at empr.com
Tags: Seizure Medication, Fibromyalgia Medication, Neuropathic Pain Medication, Neuropathic Pain, Phase 3 Clinical Trial, Lyrica, Epilepsy Medication, News
Most Recently Shared on June 21, 2011 at 2:56 pm By:
MPR News: Phase 3 Study of Lyrica for Central Neuropathic Pain: Pfizer announced study results from its Phase 3 ... http://bit.ly/kJSCXQ
Pfizer's Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
medicalnewstoday.com — “Pfizer Inc. (NYSE: PFE) announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoi” View full resource at medicalnewstoday.com
Most Recently Shared on June 22, 2011 at 5:05 pm By:
MNT Pain News Pain Management and Health News
Pfizer's Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord In... http://mnt.to/3Xxq
Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint
news-medical.net — “Pfizer Inc. announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica compared to placebo.” View full resource at news-medical.net
Most Recently Shared on June 22, 2011 at 5:48 am By:
Epilepsy News: Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint: Pfizer Inc. annou... http://bit.ly/irWH6C
Advertisement
